Global agreement signed

Article

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Leica's ophthalmic portfolio will be available to B + L, ranging from routine cataract microscopes to high-end retinal systems and including the Leica M822 for cataract procedures which combines LED and halogen lighting for a stable red reflex.

Executive vice president and president of Bausch + Lomb, John Barr, stated, "We are happy to announce the partnership of two leading companies in the field of eye surgery. Bausch + Lomb is a perfect partner for companies, such as Leica Microsystems, looking to broaden their market reach through a powerful worldwide commercial infrastructure."

"Leica Microsystems is a trusted, established brand in the industry and the company is known for their innovative microscopes and scientific instruments," continued Mr Barr. "We are excited to offer Leica surgical microscopes, as they enhance our ability to offer a ‘one-stop shop’ for an ophthalmic surgeons’ needs, while also accelerating the growth of our business.”

Eoghan O'Lionaird, president of Leica Microsystems, commented, "Through this partnership with Bausch + Lomb, we will be able to provide more patients around the world with better access to our world-leading imaging systems. We are pleased to have such a respected and innovative company as Bausch + Lomb as our partner. Our customers, their patients, and our business will benefit from this collaboration as ophthalmic surgeons will have a single source supplier for their equipment needs."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.